Taiwan Advanced Nanotech Inc.

TPEX:6797 Stock Report

Market Cap: NT$663.8m

Taiwan Advanced Nanotech Past Earnings Performance

Past criteria checks 0/6

Taiwan Advanced Nanotech's earnings have been declining at an average annual rate of -33.2%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 74% per year.

Key information

-33.2%

Earnings growth rate

-33.9%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-74.0%
Return on equity-23.5%
Net Margin-119.4%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Taiwan Advanced Nanotech's (GTSM:6797) Solid Profits Have Weak Fundamentals

Apr 08
Taiwan Advanced Nanotech's (GTSM:6797) Solid Profits Have Weak Fundamentals

Should We Be Delighted With Taiwan Advanced Nanotech Inc.'s (GTSM:6797) ROE Of 24%?

Feb 10
Should We Be Delighted With Taiwan Advanced Nanotech Inc.'s (GTSM:6797) ROE Of 24%?

Revenue & Expenses Breakdown

How Taiwan Advanced Nanotech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:6797 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24200-23813663
31 Mar 24223-22314273
31 Dec 23246-20814783
30 Sep 23265-22814896
30 Jun 23398-159164109
31 Mar 23634-69184111
31 Dec 221,327326197109
30 Sep 221,658528206103
30 Jun 221,88063719793
31 Mar 221,92665618186
31 Dec 211,92862618482
30 Sep 212,34681619476
30 Jun 212,53593217969
31 Mar 212,33490315455
31 Dec 201,71961811843
30 Sep 209242977331
30 Jun 20356565724
31 Mar 20235105224
31 Dec 19114-374624
31 Dec 18102-213819
31 Dec 1762-142218

Quality Earnings: 6797 is currently unprofitable.

Growing Profit Margin: 6797 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6797 is unprofitable, and losses have increased over the past 5 years at a rate of 33.2% per year.

Accelerating Growth: Unable to compare 6797's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 6797 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).


Return on Equity

High ROE: 6797 has a negative Return on Equity (-23.53%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:01
End of Day Share Price 2024/12/25 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Taiwan Advanced Nanotech Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution